Oncology Institute Inc当前公司基本面数据相对稳定,增长潜力很大。当前估值合理,在医疗服务供应商行业排名48/78位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价6.50。中期看,股价处于平稳状态。近一个月,市场表现较强,技术面和基本面综合得分较高,较强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。
Oncology Institute Inc评分
相关信息
行业排名
48 / 78
全市场排名
204 / 4578
所属行业
医疗服务供应商
压力支撑
由于公司未披露,未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
4
位分析师
买入
评级
6.500
目标均价
+104.40%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议
Oncology Institute Inc亮点
亮点风险
The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The Company also provides management services to over 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The Company also provides management services to over 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
公司代码TOI
公司Oncology Institute Inc
CEOVirnich (Daniel)
网址https://theoncologyinstitute.com/
常见问题
Oncology Institute Inc(TOI)的当前股价是多少?
Oncology Institute Inc(TOI)的当前股价是 3.390。
Oncology Institute Inc的股票代码是什么?
Oncology Institute Inc的股票代码是TOI。
Oncology Institute Inc股票的52周最高点是多少?
Oncology Institute Inc股票的52周最高点是4.880。
Oncology Institute Inc股票的52周最低点是多少?
Oncology Institute Inc股票的52周最低点是0.193。
Oncology Institute Inc的市值是多少?
Oncology Institute Inc的市值是330.76M。
Oncology Institute Inc的净利润是多少?
Oncology Institute Inc的净利润为-53.01M。
现在Oncology Institute Inc(TOI)的股票是买入、持有还是卖出?
根据分析师评级,Oncology Institute Inc(TOI)的总体评级为买入,目标价格为6.500。
Oncology Institute Inc(TOI)股票的每股收益(EPS TTM)是多少
Oncology Institute Inc(TOI)股票的每股收益(EPS TTM)是-0.634。